C07K 16/1271
Micrococcaceae
Official title: Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
C07K16/1271 (Micrococcaceae) appears on 413 US grants and 575 published applications in this corpus.
Search patents in C07K- Granted patents
- 413
- Published applications
- 575
- Assignees
- 259
- Inventors
- 873
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 5 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 5 | 0 |
| 2002 | 5 | 10 |
| 2003 | 4 | 11 |
| 2004 | 4 | 13 |
| 2005 | 6 | 14 |
| 2006 | 8 | 9 |
| 2007 | 5 | 13 |
| 2008 | 4 | 23 |
| 2009 | 8 | 12 |
| 2010 | 13 | 17 |
| 2011 | 11 | 24 |
| 2012 | 14 | 23 |
| 2013 | 17 | 27 |
| 2014 | 27 | 38 |
| 2015 | 18 | 51 |
| 2016 | 30 | 48 |
| 2017 | 27 | 30 |
| 2018 | 34 | 31 |
| 2019 | 27 | 40 |
| 2020 | 28 | 34 |
| 2021 | 32 | 26 |
| 2022 | 14 | 21 |
| 2023 | 16 | 19 |
| 2024 | 13 | 23 |
| 2025 | 10 | 7 |
| 2026 | 7 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Rifamycin analogs and antibody-drug conjugates thereof25 Aug 2026US 12,715,881 B2Regeneron Pharmaceuticals, Inc.
- Device, procedure and system for detecting bacterial pathogens including methicillin-resistant Staphylococcus aureus or clostridium difficile26 May 2026US 12,638,414 B2
- Compositions and methods for treatment of liquid cancers7 Apr 2026US 12,594,301 B2Beam Therapeutics Inc.
- Antibody specific to Staphylococcus aureus, therapeutic method and detection method using same24 Mar 2026US 12,583,913 B2
- Method for separation of antibodies or antibody fragments being devoid of an Fc region capable of binding to protein A17 Feb 2026US 12,552,857 B2Cytiva BioProcess R&D AB
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Methods and compositions for treating staphylococcal infections27 Aug 2026US 2026/0250425 A1The University of Chicago
- Therapeutic vhh antibodies against alpha-hemolysin from staphylococcus aureus6 Aug 2026US 2026/0226142 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Method for generating bispecific proteins23 Jul 2026US 2026/0209390 A1
- Anti-microbial antibody signatures related to lung tumors and uses thereof9 Jul 2026US 2026/0194524 A1Arizona Board of Regents on behalf of Arizona State University
Most cited
By later US patents
- Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants92US 5,585,098 AOvimmune, Inc. · 1996
- Broadly reactive opsonic antibodies that react with common staphylococcal antigens81US 5,571,511 AU.S. Government · 1996
- Staphylococcal immunotherapeutics via donor selection and donor stimulation79US 6,692,739 B1Inhibitex, Inc. · 2004
- Production of humanized antibodies in transgenic animals68US 7,129,084 B2Therapeutic Human Polyclonals, Inc. · 2006
- Methods and compositions for the direct concentrated delivery of passive immunity67US 5,530,102 A1996